Fiocarz Census IFA industries pointed out similar to 2013, but with the probability of expansion
A. Lack of Drug Shadam in Pharmacies It may seem timely, but often the source of the problem is the availability Active Pharmaceutical Input (IFA)Need to make its preparation. Without it, the Pharmaceutical Tablets, capsules or injectables cannot be produced such as Technical Advisor George Costa to the Vice Presidency of Health Product and innovation at the Oswaldo Cruz Foundation (Fiocarz).
According to Entity, make sure Product These inputs are not only a financial problem but but also Strategic for the countryReducing and strengthening the risk of shortness National sovereignty in health.
Costa is one of those responsible IFA National CensusS, it is completed in Brazil. The study revealed, currently 40 iPharmochemical Produce these inputs that are considered as necessary Medicine preparation. In 2013, this number 36, which represents a modest increase in 12 years.
Data, however, concerns the experts. Today, there are about 2,000 IFAS National Health Surveillance Agency (Anvisa) Wandering in the national territory, but only 100 of them are produced internally. “This means that we are only making 5% of the country’s needs,” the adviser explained Fiocarz.
A. Dependence on importing IFAs This causes the country to danger the shortage of the country, which directly affects the supply of medicines.
“In the absence of a medicine in the pharmacy, the problem is often in the CE industry that makes tablets or injectors, but when there is no IFA needed for its production,” Costa said.
A. Brazilian Association of Pharmaceutical Inputs Industry (ABIVIFFi) Estimate that Brazil is needed Spread the IFA preparation At least 20%. This percentage is a strategic problem for the sovereignty of the Brazilian CE sector if there are major suppliers, China and IndiaClose the export.
“As it happened. India, in the early months of the Covid -19 epicenter, did not sold us,” said the president of the Norbero Honorato Prestige Junior Abiqifi.
Prestes compares Brazilian situation USAIt also imports 70% of the required inputs produced by China and India. According to him, the difference between the two cases is that when the supply stops, the US can respond – and companies are in danger of incentives for companies, regardless of cost.
“France did this, many countries responded to the industry and ‘the room’s their bases room’.
Brazil has the advantage of industrial competition
Marked by a positive position Fiocarz Census That’s a lot of it Industries This sector works IdleThis allows the rapid growth in production with low investments.
The 40 Formochemical Industries Product IFAS is not brassL, 80%of them, according to the study, the structure of Research and development (P&D.. In government agencies such as the Butanton and Feocarz Institute that is not for profit, the innovation cooperation can reach 50% of the gross income. And in private companies, the investment reaches 16%.
“It is very positive and we understand the productivity capacity and actual product growth in tons,” said Fiocarz’s technical adviser.
There are two CE shades Pharmacemical DivisionCrystalia Laboratory and Libs. The census is virtually recognized as 100% national capital Globe, Nortek E. Blanger. And Biomangunhose Public Institutions (Fiococrez), Butanton Institute, Ejquial Dias Foundation, Vital Brazilian Institute and TechPar are only working in the biotechnology field.
“Brazil has a great opportunity for expansion. With appropriate incentive procedures, we can double the production of our national IFAs in a short time,” Prestes said. Costa adds that the profile of pharmacochemicals will also strengthen the public policy “National capital in Brazil”.
In addition to the expansion capacity, the country has a specific competitive purpose: the IFAS produced by the extraction of animalsEspecially by cattle and pigs. The Fiocarz adviser believes that Brazil has the advantage of the competition in this field because it is one of the largest Halflas and pigs From the world.
According to IBGE, in 2023, only the head of the bulls and cows, Brazil’s total of 238,626,442. It allows the country to produce IFAs by the extraction of animals Large scale for the domestic and export market.
These inputs are required in the product HeparinUsed as an anticoag in medication; Chondroetin sulfateUsed against joint problems such as osteoarthritis; And and Peptonas – Culture is used as a medium in fermentation and tissue cultivation processes, but they are not drugs itself.
FiOCRZE: Technician ended the first batch of the first batch of Covid -19 vaccine in 2022 (photo/reproduction)
In spite of The purpose of Brazil The Costa documented that many companies have complained about “unfair competition” in the area, according to census. Brazilian CE industries, which produce drugs with heparin, prefer to import China’s input instead of buying from national industries.
It weakens local producers and hinder production chain growth in Brazil. “Most foreign companies will buy our inputs, bovine and pork visa and go out at very cheap prices,” said Costa of Fiocris.
The head of the Fiocarz study will import this input to these companies a Naming the usual Mercosur (NCM) It does not comply with the imported product to pay less tax.
“This is a fraud that can harm the national producer because they do not collect taxes to raise the country,” he said. National Pharmacochemical Industries indicated the need to be alerted according to census calculations The Ministry of Development, Industry, Commerce and Services (MDIC) To take action.
According to Costa, the next step National Census of IFAS MDIC and searching for Ministry of Health To display the X-ray of this sector and Define strategic inputs For national product. The goal is to explain Public policies To promote this product.
An example of the medicine Shadam suitable for this profile is the L-Asperajins enzyme, which is prescribed to the treatment of children’s leukemia and is not produced in Brazil.
“We have had a serious shortage of product in the past and have also created a multidisciplinary group to address this emergency. I have warned about the loss of many pediatric patients due to the availability of an emotional appeal at one of these meetings.
The study also strengthens a need Industrial policy On the opposite side Strengthens the national product of IFAS And justifies the expansion of Government-private partnershipsPartnerships for local development and innovation program (PDIL) and manufacturing development (PDP).
According to data launched this week, the partnerships broke the record in 2024. Approximately 350 projects were submitted, which was about three times more than the last time the last was launched.
George Costa has concluded that it is essential to consider the area in 15 to 20 years to become a relevant actor in the country CE shadow Strategic For one Industrial policy In the long run regardless of political changes.
. In this scenario, the famous actor, “concludes the technical adviser of Fiococ..
